Fortrea Holdings Inc. (FTRE): Depreciation & Amortization
$78.00M
Year ended 2025-12-31
$78.30M
Trailing 12 months to 2026-06-30
-5.9%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $78.00M | -10.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $86.90M | -11.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $98.00M | +4.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $93.60M | -43.7% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $166.30M | n/a | 2024-03-13, From 2021-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $78.00M | -10.2% |
| Natera, Inc. (NTRA) | 2025-12-31 | $41.76M | +34.9% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $136.10M | +8.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $570.00M | +15.6% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $681.10M | +5.8% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗